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Background: To investigate the mechanisms of lung adenocarcinoma cell metastasis and provide a theoretical
basis for the in-depth study of lung adenocarcinoma.
Methods: A549 cells are incubated with different concentrations of Furin inhibitor for indicated times. The
proliferation and migration were confirmed with MTT, colony formation, wound Healing and Transwell assayes.
Hochest 33342 / PI double staining was used to detect apoptosis. Cell migration and apoptosis associated proteins
were analysed by enzyme-linked immunosorbent assay (ELISA) and western blot.
Results: We have found that Furin inhibitor play a significant role in inhibition A549 cell growth. And we also
found cell migration was inhibited significantly upon Furin inhibitor treatment.
Conclusion: The proliferration and migration of A549 cell were inhibited by Furin inbitor through down-regulation
the expression of migration and apoptosis related proteins.
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Lung cancer is one of the most serious threats to human
health in the world, and the incidence is increasing year
by year [1]. It was estimated that the number of the pa-
tients dying from lung cancer was larger than the total
number of patients dying from prostate cancer and colo-
rectal cancer one year [2]. Metastasis and recurrence is
the leading cause of death in patients with lung cancer,
about 90% of the lung cancer patients died from tumor
metastasis [3]. Thus depth study on the molecular mech-
anism of lung cancer invasion and metastasis is necessary.
Furin is an important member of the family of pro-
protein processing enzyme and highly expressed in a
variety of tumors [4-6]. Many proteins which are closely
related to tumor development, including Notch, Wnt,
MT1-MMP, VEGF, etc., must be cut by Furin [4,7]. So,
Furin expression can be used as the marker of tumor
progression or as prognostic indicators [8,9]. Mbikay,
etc. [10] studies have shown that Furin is highly expressed
in lung cancer, and is closely related to lung cancer devel-
opment. In our present study, we apply Furin inhibitor* Correspondence: xusongtao-008@163.com
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unless otherwise stated.a1-PDX to detect the effect on the migration and inva-
sion of A549 cells.Materials and methods
Human lung adenocarcinoma cell line A549 was pur-
chased from Chinese Academy of Medical Sciences Pe-
king Union cell libraries, cultured in RPMI1640 medium
(Gibco, USA) contained with 10% fetal bovine (FBS),
100 units/mL penicillin and 100 μg/mL streptomycin
at 37°C, 5% CO2 and humidity.
Furin inhibitor a1-PDX (Merck No.126850-2.5 MG)
was dissolved in DMSO. Rabbit anti-human VEGF-C,
VEGF-D, MT1-MMP, Caspase-3, Caspase-9, Bcl-2 and
GAPDH antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, USA). Anti-rabbit IgG-HRP
were purchased from Sigma (Sigma, USA); MTT, Hochest
33342, Transwell kit were purchased from Promega Cor-
poration; MMP2, MMP9 ELISA kits were purchased from
Nanjing Jiancheng Biological Reagent Company. Other re-
agents were of analytical grade.Cell proliferation studies by MTT assay
A549 cells in logarithmic growth phase were seeded in 96-
well plate (5 × 103 per well) for 24 h. Various concentrations. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Effect of a1-PDX on the proliferation of A549 cell. A549 cells were treated with a1-PDX for indicated times, the proliferation was
detected with MTT assay (A). Individual cell was seeded on the 6-well plate, followed with colony analysis (B). Data are expressed as overall
Mean ± SE from three independent experiments. (*P < 0.05, vs control).
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24 h~96 h. MTT reagent (5 mg/mL) was added to each well
and incubated for 4 h at 37°C. The formazan crystals were
solubilized by the addition of 150 μL DMSO to each well.
The optical density at 490 nm was measured and cell viabil-
ity was determined by the growth curve.
Colony formation ability of A549 cell
Monolayer cultured cells were pipetted into individual
cells, then suspended in 10% FBS-containing RPMI 1640Figure 2 A1-PDX induce apoptosis in A549 cells. Cell apoptosis was de
expressed as Mean ± SE from three independent experiments. (*P < 0.05 vmedium, after that we inoculated these cells in petri dishes.
Different concentrations of a1-PDX (200 nM, 400 nM) were
added and incubated for 2 weeks. Then immobilized and
stained for 10 min by Giemsa dye. After washing and air
drying, clone numbers were directly counted and analyzed.
Hochest 33342 / PI staining for apoptosis analysis
A549 cells were treated by different concentrations of
a1-PDX for 48 h and washed twice with cold PBS, then
incubated with 5 μL DAPI /PI staining buffer for 15 mintermined by Hoechst/PI double staining (A, B, C, D). Data are
s control).
Figure 3 Effect of a1-PDX on the cell migration by wound healing assay. Monolayer A549 cell grew to 100% confluent and wounded by a
sterile 200 μl pipette tip, the ability of cell migration was monitored with an inverted microscopy equipped with a digital camera (A). Statistical
analysis of three independent experiments (B) (*P < 0.05 vs control).
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apoptosis was determined.
Monolayer cell wound healing assay
The 100% confluent monolayer cells were scraped with
sterile 200 μL pipette tip and cell debris was washedFigure 4 A549 cell invasion ability upon a1-PDX treatment. The invasi
statistical analysis (D) (*P < 0.05, **P < 0.01 vs control).with PBS. The cells migrated into the wounded areas
and these process were photographed at the indicated
times with an inverted microscopy equipped with a digital
camera. The extent of healing was defined as the ratio of
the difference between the original and the remaining
wound areas compared with the original wound area.on cells were detected by Transwell assay (A, B, C) and counted for
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A549 cells (1 × 105) were incubated with different con-
centrations of a1-PDX on the upper chamber of the trans-
well, containing 200 μL of RPMI1640 medium without
10% FBS. Transwell lower chamber is filled with 500 μL of
complete RPMI1640 medium containing 10% FBS. The
cells were allowed to migrate for 48 h, then fixed and
stained with 0.1% crystal violet for 10 min. The migrated
clones were photographed under an optical microscope.
The cell numbers were counted at 12 different areas.Western blot analysis
A549 cells were treated and collected as described above.
Cells were lysed in RIPA buffer (50 mM Tris (pH 7.4),
150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1% sodium
deoxycholate, 5 mM EDTA, 100 mM NaF, and 1 mM
Na3VO4) containing protease inhibitor cocktail for 30 min
on ice, and then centrifuged for 30 min at 30000 g. Equal
total proteins were electrophoresis by 12% SDS-PAGE
gel, followed by transferred to PVDF membranes using
a wet transblot system (Bio-Rad, Hercules, CA). The
membranes were blocked for 1 h at room temperature
with 5% nonfat dry milk and incubated overnight at 4°CFigure 5 Effect of a1-PDX on the expression of migration and apopto
medium were detected by ELISA assay (A and B). The data represent the M
The expression of cell migration and apoptosis proteins in A549 cells werewith antibodies against MT1-MMP, VEGF-C, VEGF-D
and GAPDH (1:1000). After washing, membrane was in-
cubated for 1 h with HRP-conjugated goat anti-rabbit sec-
ondary antibody diluted 1:5,000 in PBST. After further
washing and processing using Super Signal West Pico
chemiluminescent substrate (Pierce, USA), the membrane
was exposed to Fujifilm LAS3000 Imager (Fuji, Japan).
The band densities of the western blots were normalized
and compared to the relevant GAPDH band density with
Image J Analyst software (NIH).Enzyme-linked immunosorbent assay
A549 cells were treated as previously described. Con-
centrations of MMP-9, MMP-2, VEGF in the cell culture
supernatants were quantified using ELISA kits (R&D
Systems, USA). Each sample was repeated 5 times.Statistical analysis
The experiments were carried out in triplicate and the
data were compared to control group. Statistical analysis
was performed by SPSS13.0, measurement data using
paired t-test and ANOVA. A P value of less than 0.05
was thought to indicate statistical significance.sis proteins in A549 cells. MMP2 and MMP9 in SW480 cell culture
ean ± SE from three independent experiments. (*P < 0.05 vs control ).
detected with western blot (C and D).
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Effects of a1-PDX on proliferation and colony formation
abilities of A549 cell
A549 cell growth was inhibited upon treatment with a1-
PDX for over 48 hours (Figure 1A). Then, colony forma-
tion assay was performed to detect the clones of A549
cell. The result showed that the colony formation ability
of A549 cell was decreased significantly compared to the
control group (Figure 1B).
Effects of a1-PDX on apoptosis of A549 cells
To explore the mechanism of a1-PDX on A549 cell growth
inhibition, we first used Hochest33342/PI double staining
to detect the morphological change of apoptosis cells. The
results showed that a1-PDX can induce apoptosis of A549
cells (Figure 2).
Effects of a1-PDX on A549 cell migration and invasion
To study whether the migration and invasion of A549
cells were regulated by a1-PDX, we then used wound
healing and Transwell assays. Two experimental results
showed that the migration and invasion capabilities of
A549 cells were reduced evidently by a1-PDX compared
to the control group (Figures 3 and 4).
To fully understand the molecular mechanism of A549
cells migration and apoptosis regulated by a1-PDX, we de-
tected the expression of some proteins with Western Blot
and ELISA assay (Figure 5). The concentrations of MMP2,
MMP9 in cell culture medium reduced significantly com-
pared to the control group (Figure 5A, B). The expression
of MT1-MMP, VEGF-c and VEGF-d decreased significantly
compared to the control group (Figure 5C). However, the
expression of Caspase-3, Caspase-9 and Bcl-2 were in-
creased evidently in a1-PDX treated groups (Figure 5D).
Discussion
Tumor metastasis is a complex multi-step process. Many
proteins involve in the process of tumor metastasis. As
we all know, the tumor extracellular matrix digestion is
the most common prerequisite for tumor invasion and
metastasis. Tumor cells secrete MMP family members
(MMPs) could degrade all of the important extracellular
matrix components [11,12]. Thus, the expression of
matrix metalloproteinases could effectively reflect the
ability of tumor cell invasion. It was proven that matrix
metalloproteinase MMP2 and MMP9 degraded the base-
ment membrane was a crucial step that promote tumor
invasion and metastasis in many types of tumors [13].
In our current study, a1-PDX could not only inhibit
the expression of cell migration proteins, but also in-
crease the expression of cell apoptosis proteins, that in-
duced cell apoptosis. MT1-MMP was Furin substrates,
so MT1-MMP precursor was required to be cut by Furin
before the maturation [4]. A1-PDX reduced the enzymicactivity of Furin, thus reducing the maturation and ac-
tivation of MT1-MMP. It was further suppressed the
maturation of MMP2 and MMP9.
The enhanced expression of VEGF-C and VEGF-D
and the lymphatic metastasis of tumor cells had been
considered as a prognostic indicator of several types of
cancers [14,15]. Their precursors needed to be cut by
Furin before maturation and activation [16]. Therefore,
we also have examined the expression of VEGF-C and
VEGF-D protein in A549 cells which were treated by a1-
PDX. The results show that the expressions of VEGF-C
and VEGF-D protein are significantly reduced.
Conclusions
Taken together, we conclude that Furin inhibitor sup-
pressed A549 cell migration through down-regulating the
activity of Furin. The subsequent regulation plays a critical
role in A1-PDX-induced migration inhibition and apop-
tosis in A549 cells. Furin inhibitor may, therefore, have a
potential use as a target in the treatment of lung cancer.
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